Outpatient psychiatric care for adolescents who have recovered from cancer and have depressive disorders in remission
https://doi.org/10.17650/2073-8803-2025-20-2-34-39
Abstract
Background. The prevalence of clinically significant depression among adolescents cured of cancer reaches 15–25 %, which is 2–3 times higher than the rates in the general population of minors. This fact dictates the need to study depressive pathology in these patients.
Aim. To clarify the features of therapy for depressive disorders in patients in remission from cancer.
Materials and methods. Adolescents (50 patients aged 15 to 19 years, 28 girls and 22 boys) with oncohematological pathology (leukemia, lymphoma) were studied using a clinical and psychopathological method. By the time of examination, all patients belonged to the category of those cured of malignant disease, being in a state of remission lasting from 2 to 10 years.
Results and conclusion. The appeal to a psychiatrist was associated with complaints of depressed mood. Depending on the severity of the depressive state and the leading psychopathological syndrome, psychotherapeutic and psychopharmacological methods of treatment were used. It was concluded that for successful management of depressive manifestations it is necessary not only to use medical and non-medical methods, but also coordinated interprofessional interaction of specialists of different profiles.
Supporting agencies: The study was performed without external funding.
About the Authors
O. A. Suetina
Research Center for Mental Health;
Russian Federation
Russian Federation
Oksana Anatolyevna Suetina
34 Kashirskoe Shosse, Moscow 115522
N. E. Kravchenko
Research Center for Mental Health;
Russian Federation
Russian Federation
34 Kashirskoe Shosse, Moscow 115522
References
1. Zheludkova O.G., Polyakov V.G., Rykov M.Yu. et al. Clinical manifestations of oncological diseases in children: practical recommendations. Ed. by V.G. Polyakova, M.Yu. Rykova. Saint Petesburg: Tipografiya Mikhaila Fursova, 2017. 52 p. (In Russ.)
2. Kurtanova Yu.E., Burdukova Yu.A., Shcherbakova A.M., Ivanova A.A. Social adaptation of children with oncological diseases after long-term treatment. Sovremennaya zarubezhnaya psikhologiya = Modern Foreign Psychology 2020;9(3):127–38. (In Russ.). DOI: https://doi.org/10.17759/jmfp.2020090312
3. Ryabova T.V., Nikolskaya N.S., Stefanenko E.A. et al. The concept of “emotional distress” as a possible indicator of adaptation disorders in children/adolescents with oncological and oncohematological diseases and adults caring for them. Rossiyskiy zhurnal detskoy onkologii i gematologii = Russian Journal of Pediatric Oncology and Hematology 2019;6(4):76–82. (In Russ.). DOI: 10.21682/2311-1267-2019-6-4-76-82
4. Smulevich A.B. Depression in mental and somatic diseases. 4th edn, revised. Moscow: OOO “Izdatelstvo “Meditsinskoye informatsionnoye agentstvo”, 2015. P. 487. (In Russ.).
5. Tarasova A.V., Kupriyanova I.E., Slonimskaya E.M. et al. Personalized therapy for cancer patients with nosogenic reactions. Sibirskiy vestnik psikhiatrii i narkologii = Siberian Bulletin of Psychiatry and Narcology 2018;3(100):57–61. (In Russ.). DOI: 10.26617/1810-3111-2018-3(100)-57-61
6. Khain A.E., Kholmogorova A.B., Ababkov V.A. Emotional state and coping strategies of adolescents with oncohematological diseases. Klinicheskaya i spetsialnaya psikhologiya = Clinical and Special Psychology 2018;7(4):131–49. (In Russ.).
7. Bruce M. A systematic and conceptual review of posttraumatic stress in childhood cancer survivors. J Pediatric Psychology 2006;31(2):123–40. DOI: 10.1093/jpepsy/jsj017
8. Dantzer R., O’Connor J.C., Freund G.G. et al. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 2008;9(1):46–56. DOI: 10.1038/nrn2297
9. Dietrich J., Prust M., Kaiser J. Chemotherapy, cognitive impairment and hippocampal toxicity. Neuroscience 2015;309:224–32. DOI: 10.1016/j.neuroscience.2015.06.016
10. Pai A.L.H., Kazak A.E., Schneider S. et al. Psychosocial outcomes in adolescent survivors of childhood cancer. J Clin Oncol 2021;39(15):1717–28. DOI: 10.1200/JCO.20.02576
11. Pinquart M. Body image of children and adolescents with chronic illness: A meta-analytic comparison with healthy peers. Body Image 2013;10(2):141–8. DOI: 10.1016/j.bodyim.2012.10.008
12. Potash M., Breitbart W. Affective disorders in advanced cancer. Hematol Oncol Clin North Am 2002;16:671–700. DOI: 10.1016/s0889-8588(02)00013-8
13. Surveillance, Epidemiology, and End Results (SEER) Program SEER Cancer Statistics Review (CSR) 1975–2017. National Cancer Institute, 2020. Available at: https://seer.cancer.gov/csr/1975_2017/.
14. Weaver M.S., Heinze K.E., Kelly K.P. et al. Establishing psychosocial palliative care standards for children and adolescents with cancer and their families: An integrative review. Palliat Med 2019;33(2):212–23. DOI: 10.1177/0269216315583446
15. Wein S., Sulkes A., Stemmer S. The oncologist’s role in managing depression, anxiety and demoralization with advanced cancer. Cancer J 2010;16(5):493–9. DOI: 10.1097/PPO.0b013e3181f28b64
16. Wiener L., Battles H., Zadeh S. et al. Mental health interventions for survivors of pediatric cancer. Pediatric Blood Cancer 2020;67(3):e28234. DOI: 10.1002/pbc.28234
Review
For citations:
Suetina O.A., Kravchenko N.E. Outpatient psychiatric care for adolescents who have recovered from cancer and have depressive disorders in remission. Russian Journal of Child Neurology. 2025;20(2):34-39. (In Russ.) https://doi.org/10.17650/2073-8803-2025-20-2-34-39
Views:
9
Email this article 